)
Healwell AI (AIDX) investor relations material
Healwell AI Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Completed integration of Orion Health, shifting focus from episodic life science sales to recurring enterprise healthcare sales, driving operational efficiencies and a strong pipeline of enterprise deals across all geographies.
AI capabilities embedded across platforms, with significant commercial wins in North America, Middle East, and Canada, and a growing base of 1,291 physicians onboarded to AI Copilots.
Four key growth engines: HIE and clinical data unlock, SMART Suite, global life science enterprise business, and consented data in Canada, all showing strong execution signals.
Strategic goals include commercializing AI product suite, expanding scientific validation, and leveraging a CAD 23 million indirect stake in SpaceX.
IFRS net income from continuing operations was $6.4 million in Q2-2026, compared to a net loss of $4.1 million in Q2-2025.
Financial highlights
Q2 2026 revenue from continuing operations was CAD 33 million, nearly flat year-over-year, with H1 2026 revenue at CAD 66.2 million, up 60% year-over-year, driven by the Orion Health acquisition.
Positive adjusted EBITDA of CAD 1.1 million in Q2 2026, down from CAD 2.3 million in Q2 2025; H1 2026 adjusted EBITDA was CAD 1.9 million, up from CAD 0.1 million.
Gross profit for Q2 2026 was CAD 17.9 million (gross margin 54%), compared to CAD 18.7 million (56%) in Q2 2025; H1 2026 gross profit was CAD 37.4 million, up 62% year-over-year.
Operating cash flow for H1 2026 was CAD 4.5 million, a CAD 14.4 million improvement year-over-year, strengthening liquidity and covenant compliance.
Operating expenses for Q2 2026 decreased 9% year-over-year to $24.1 million.
Outlook and guidance
Targeting approximately 10% adjusted EBITDA margin by year-end 2026, with margin expansion expected from enterprise sales and cost actions.
Anticipates lower end of 30%-50% growth for AI & Data Science segment in 2026, with stronger growth expected in 2027 as enterprise deals ramp.
Healthcare software segment expected to maintain high single-digit growth rates.
Revenue recognition for enterprise deals expected to accelerate in Q3 and Q4 as delivery milestones are met.
Plans to monetize SpaceX holdings as lock-up expires to further strengthen liquidity.
- Q1 revenue rose 316% to CAD 33.2M, with positive adjusted EBITDA and expanding global AI adoption.AIDX
Q1 2026 - Record 2025 revenue and first positive Adjusted EBITDA highlight rapid AI and software growth.AIDX
Q4 2025 - Q3 revenue jumped 354% to CAD 30.4M, with positive Adjusted EBITDA and global AI expansion focus.AIDX
Q3 2025 - Record revenue growth and first positive EBITDA mark a strategic shift to pure-play AI software.AIDX
Q2 2025 - Record Q3 revenue and major acquisitions drive rapid growth and target CAD 100M run rate in 2025.AIDX
Q3 2024 - Q2 revenue up 204% to CAD 5.44M; profitability and AI launches drive strong outlook.AIDX
Q2 2024 - Record revenue growth and Orion Health acquisition set to drive EBITDA-positive results in 2025.AIDX
Q4 2024 - Q1 revenue up 208% year-over-year; Orion Health acquisition to add CAD 100M annual revenue.AIDX
Q1 2025
Next Healwell AI earnings date
Next Healwell AI earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)